Literature DB >> 8850532

Distribution and characterization of rat immunoreactive proadrenomedullin N-terminal 20 peptide (PAMP) and the augmented cardiac PAMP in spontaneously hypertensive rat.

H Inatsu1, J Sakata, T Shimokubo, M Kitani, M Nishizono, H Washimine, K Kitamura, K Kangawa, H Matsuo, T Eto.   

Abstract

Proadrenomedullin N-terminal 20 peptide (PAMP) is a novel hypotensive peptide processed from an adrenomedullin precursor. In this study, high concentrations of immunoreactive PAMP (ir-PAMP) were detected in rat cardiac atrium and adrenal gland by the radioimmunoassay (RIA) for rat PAMP. The mean plasma concentration of rat ir-PAMP was 3.8 +/- 0.3 fmol/ml. Analysis in atrium, adrenal gland and plasma with high performance liquid chromatographies showed that most ir-PAMP emerged as one major peak at the position exactly identical to that of the authentic rat PAMP. We further investigated the tissue and plasma concentrations of rat ir-PAMP in spontaneously hypertensive rat (SHR) to elucidate the role of PAMP in hypertension. The ir-PAMP concentration in heart tissue of SHR was found to be increased compared with that of the control rat. Especially, the atrial concentration of ir-PAMP of SHR (5.66 +/- 0.78 fmol/mg wet tissue) was significantly higher than that of the control (3.29 +/- 0.22 fmol/mg wet tissue). Cardiac PAMP might have a role for the protection from systemic hypertension.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8850532

Source DB:  PubMed          Journal:  Biochem Mol Biol Int        ISSN: 1039-9712


  2 in total

Review 1.  Mid-regional pro-adrenomedullin in acute heart failure: a better biomarker or just another biomarker?

Authors:  Mihael Potocki; Ronny Ziller; Christian Mueller
Journal:  Curr Heart Fail Rep       Date:  2012-09

2.  The effect of adrenomedullin and proadrenomedullin N-terminal 20 peptide on angiotensin II induced vascular smooth muscle cell proliferation.

Authors:  Jian Ma; Yinglu Feng; Zaiquan Li; Chaoshu Tang
Journal:  Iran J Basic Med Sci       Date:  2016-01       Impact factor: 2.699

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.